Neuronal cell death in Wernicke's encephalopathy: Pathophysiologic mechanisms and implications for PET imaging

Metabolic Brain Disease

Volumn 11, Issue 1, 1996, Pages 71-79

  Leong, Dorothy K ^a   Butterworth, Roger F ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

GABA benzodiazepine receptor complex; peripheral type benzodiazepine receptors; positron emission tomography, 3H PK11195, 3H Ro 15 1788; thiamine deficiency; Wernicke's encephalopathy

Indexed keywords

4 AMINOBUTYRIC ACID; BENZODIAZEPINE RECEPTOR; FLUMAZENIL; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE;

AUTORADIOGRAPHY; BINDING SITE; BRAIN MAPPING; CELL DEATH; CONFERENCE PAPER; DIAGNOSTIC IMAGING; ENERGY METABOLISM; HUMAN; NERVE CELL; NONHUMAN; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; THIAMINE DEFICIENCY; WERNICKE ENCEPHALOPATHY;

ANIMALS; CELL DEATH; HUMANS; NERVE DEGENERATION; RATS; TOMOGRAPHY, EMISSION-COMPUTED; WERNICKE ENCEPHALOPATHY;

EID: 0029914676     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02080932     Document Type: Conference Paper

References (61)

1. Aikawa, H., Watanabe, I.S., Furuse, T., Iwasaki Y., Satoyoshi, E., Sumi, T., and Moroji, T. (1984). Low energy levels in thiamine-deficient encephalopathy. J. Neuropath. Exp. Neurol. 43:276-287.
2. Benavides, J., Fage, D., Carter, C., and Scatton, B. (1987). Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damage. Brain Res. 421:167-172.
3. 3H-Ro5-4864 in promary cultures of astrocytes. Brain Res. 341:41-49.
4. Bettendorff, L. (1994). Thiamine in excitable tissues: Reflections on a non-cofactor role. Metab. Brain Dis. 9:183-209.
5. Butterworth, R.F. (1993). Pathophysiologic mechanisms responsible for the reversible (thiamine-responsive) and irreversible (thiamine non-responsive) neurological symptoms of Wernicke's encephalopathy. Drug and Alcohol Rev. 12:315-322.
6. Butterworth, R.F., Gaudreau, C., Vincelette, J., Bourgault, A.M., Lamothe, F., and Nutini, A.M. (1991). Thiamine deficiency and Wernicke's encephalopathy in AIDS. Metab. Brain Dis. 6:207-212.
7. Butterworth, R.F., Giguere, J.F., and Besnard, A.M. (1985). Activities of thiamine-dependent enzymes in two experimental models of thiamine-deficiency encephalopathy. 1. The pyruvate dehydrogenase complex. Neurochem Res. 10:1417-1428.
8. Butterworth, R.F., Giguere, J.F., and Besnard, A.M. (1986). Activities of thiamine-dependent enzymes in two experimental models of thiamine deficiency encephalopathy. 2. α-ketoglutarate dehydrogenase. Neurochem Res. 11:567-577.
9. Butterworth, R.F., and Heroux, M. (1989). Effect of pyrithiamine treatment and subsequent thiamine rehabilitation on regional cerebral amino acids and thiamine-dependent enzymes. J. Neurochem. 52:1079-1084.
10. Calingasan, N.Y., Baker, H., Sheu, K.F., and Gibson, G.E. (1995). Blood-brain barrier abnormalities in vulnerable brain regions during thiamine deficiency. Exp. Neurol. 134:64-72.
11. Charness, M.E., and DeLaPaz, R.L. (1987). Mammillary body atrophy in Wernicke's encephalopathy: antemortem identification using magnetic resonance imaging. Ann. Neurol. 22:595-600.
12. Cooper, J. R., and Pincus, J. H. (1979). The role of thiamine in nervous tissue. Neurochem. Res. 4:223-229.
13. Diorio, D., Welner, S.A., Butterworth, R.F., Meaney, M., and Suranyi-Cadote, B.E. (1991). Peripheral benzodiazepine binding sites in Alzheimer's Disease frontal and temporal cortex. Neurobiol. Aging 12:255-258.
14. Dreyfus, P.M., and Hauser, G. (1965). The effect of thiamine deficiency on the pyruvate decarboxyiase system of the central nervous system. Biochem. Biophys. Acta. 104:78-84.
15. Elnageh, K.M., and Gaitonde, M.K. (1988). Effect of a deficiency of thiamine on brain pyruvate dehydrogenase: enzyme assay by three different methods. J. Neurochem. 51:1482-1489.
16. Farde, L., Pauli, S., Litton, J.-E., Halldin, C., Neiman, J., and Sedvall, G. (1994). PET-determination of benzodiazepine receptor binding in studies on alcoholism. Experientia 71:143-153.
17. Gallucci, M., Bozzoa, A., Splendiani, A., Masciocchi, C., and Passariello, R. (1990). Wernicke encephalopathy: MR findings in five patients. Am. J. Roentgenology 155:1309-1316.
18. Gibson, G.E., Ksiezak-Reding, H., Sheu, K.F.R., Mykytyn, V., and Blass, J.P. (1984). Correlation of enzymatic, metabolic and behaviuoral deficits in thiamine deficiency and its reversal. Neurochem Res. 9:803-814.
19. Giguere, J.-F., and Butterworth, R.F. (1987). Activities of thiamine-dependent enzymes in two experimental models of thiamine-deficiency encephalopathy. 3. Transketolase. Neurochem. Res. 12:305-310.
20. Hakim, A. (1984). The induction and reversibility of cerebral acidosis in thiamine deficiency. Ann. Neurol. 16:673-679.
21. Hakim, A.M. and Pappius, H.M. (1983). Sequence of metabolic, clinical, and histological events in experimental thiamine deficiency. Ann. Neurol. 13:365-375.
22. Harata, N., and Iwasaki, Y. (1995). Evidence for early blood-brain barrier breakdown in experimental thiamine deficiency in the mouse. Metab. Brain Dis. 10:159-174.
23. Harper, C. (1983). The incidence of Wernicke's encephalopathy in Australia- a neuropathological study of 131 cases. J. Neurol. Neurosurg. Psychiatry 46:593-598.
24. Harper, C., Giles, M., and Finlay-Jones, R. (1986). Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy. J. Neurol. Neurosurg. Psychiatry 49:341-345.
25. Hazell, A.S., Butterworth, R.F., and Hakim, A.M. (1993). Cerebral vulnerability is associated with selective increase in extracellular glutamate concentration in experimental thiamine deficiency. J. Neurochem. 61:1155-1158.
26. Héroux, M., and Butterworth, R.F. (1992). Animal models of the Wernicke-Korsakoff Syndrome. In: (A. Boulton, G. Baker, and R.F. Butterworth, eds)Neuromethods, Vol. 22: Animal Models of Neurological Disease. II., Humana Press, New York, pp 95-131.
27. Héroux, M., and Butterworth, R.F. (1995). Regional alterations of thiamine phosphate esters and of thiamine diphosphate-dependent enzymes in relation to function in experimental Wernicke's encephalopathy. Neurochem. Res. 20:87-93.
28. Holthoff, V.A., Koeppe, R.A., Frey, K.A., Penney, J.B., Markel, D.S., Kuhl, D.E., and Young, A.B. (1993). Positron emission tomography measures of benzodiazepine receptors in Huntington's disease. Ann. Neurol. 34:76-81.
29. Horecker, B.L., and Smyrniotis, P.Z. (1953). The coenzyme function of thiamine pyrophosphate in pentose metabolism. J. Am. Chem. Soc. 75:1009-1010.
30. Ishii, K., Sarai, K., Sanemori, H., Kawasaki, T. (1979). Analysis of thiamine and its phosphate esters by high-performance liquid chromatography. Anal. Biochem. 97:191-195.
31. Junck, L., Olson, J.M.M., Ciliax, B.S., Koeppe, R.A., Watkins, G.L., Jewett, D.M. et al. (1989). PET imaging of human gliomas with ligands for the peripheral benzodiazepine binding site. Ann. Neurol. 26:752-758.
32. Kessler, R.M., Clark, C.M., Parker, E.S., Martin, P., Sokoloff, L., Ebert, M.H., and Mishkin, M. (1984). Regional cerebral glucose use in patients with alcoholic Korsakoff's Syndrome. Clin. Nucl. Med. (Abstr.) 9:65.
33. Kinnersley, H.W., and Peters, R.A. (1930). Brain localization of lactic acidosis in avitaminosis B1 and its relation to the origin of symtoms. Biochem. J. 24:711-722.
34. Langlais, P.J., and Mair, R.G. (1990). Protective effects of the glutamate antagonist MK801 on pyrithiamine-induced lesions and amino acid changes in rat brain. J. Neurosci. 10:1664-1674.
35. Langlais, P.J., and Zhang, S.X. (1993). Extracellular glutamate is increased in thalamus during thiamine deficiency-induced lesions and is blocked by MK801. J. Neurochem. 61:2175-2182.
36. 3H-PK11195 in vulnerable regions of the rat brain in thiamine deficiency encephalopathy. J. Cereb. Blood Flow and Metab. 14:100-105.
37. Leong, D.K., Oliva, L., and Butterworth, R.F. (1995). Immunohistochemical studies of the glial response to thiamine deficiency in the rat using antibodies to GFAP and ED1(macrophage lysosomal antigen). Soc. Neurosci. Abst., Vol. 21 (2), p.814.
38. Leong, D.K., Oliva, L., and Butterworth, R.F. (1996). Quantitative autoradiography using selective radioligands for central and peripheral-type benzodiazepine receptors in experimental Wernicke's encephalopathy: Implications for PET imaging. Alcoholism: Clin. Exp. Res. (In press)
39. 11C-flumazenil binding to benzodiazepine receptors in chronic alcohol-dependent men and healthy controls. Psychiat. Res. 50:1-13.
40. McCandless, D.W., and Schenker, S. (1968). Encephalopathy of thiamine deficiency: Studies of intracerebral mechanisms. J. Clin. Invest. 47:2268-2280.
41. McDowell, J.E., and LeBlanc, H.J. (1984). Computed tomographic findings in Wetnicke-Korsakoff Syndrome. Arch. Neurol. 41:453-454.
42. Mensing, J.W.A., Hoogland, P.H., and Sloof, J.L. (1984). Computed tomography in the diagnosis of Wernicke's encephalopathy: a radiological-neuropathological correlation. Ann. Neurol. 16:363-365.
43. 3H-PK11195 binding in rat cerebral cortex following a local ischaemic lesion. J. Cereb. Blood Flow and Metab. 11:314-322.
44. Myers, R. (1993). Mitochondrial benzodiazepine receptor ligands as indicators of damage in the CNS: their application in positron emission tomography. In: (Giesen-Crouse, E., ed.) Peripheral Benzodiazepine Receptors, Academic Press, San Diego, CA, pp 235-273.
45. 3H-Ro5-4864 in cultured microglial cells. Soc. Neurosci. Abst., 20:365.3.
46. Parker, W.D., Jr, Haas, R., Stumpf, D.A., Parks, J., Eguren, L.A., and Jackson, C. (1984). Brain mitochondrail metabolism in experimental thiamine defciency. Neurol. 34: 477-481.
47. Peters, R.A. (1936). The biochemical lesion in vitamin B1 deficiency. Application of modern biochemical analysis in its diagnosis. The Lancet i:1161-1164.
48. Piani, D., Frei, K., Do, K.Q., Cuenod, M., and Fontana, A. (1991). Murine brain macrophages induce NMDA receptor neurotoxicity in vitro by secreting glutamate. Neurosci. Lett. 133:159-162.
49. Pincus, J.H. ,and Wells, K. (1972). Regional distribution of thiamine-dependent enzymes in normal and thiamine-deficient brain. Exp. Neurol. 37:495-501.
50. Rindi, G., and deGiuseppe, L. (1961). A new chromatographic method for the determination of thiamine and its mono-, di- and triphosphates in animal tissues. Biochem. J. 78:602-606.
51. 18[F]-FDG as PET markers of epileptic foci. J. Neurol. Neurosurg. Psychiatry 56:615-621.
52. 3H-Ro5-4864 benzodiazepine binding in the kainate-lesioned striatum and Huntington's diseased basal ganglia. Brain Res. 248:396-401.
53. Thomson, A.D., Jeyasingham, M.D., Pratt, O.E., and Shaw, G.K. (1987). Nutrition and alcoholic encephalopathies. Acta Med. Scand., Suppl. 717:55-65.
54. Torvik, A., Lindboe, C.F., and Rogde, S. (1982). Brain lesions in alcoholics. J. Neurol. Sci. 56:233-248.
55. Torvik, A. (1985). Two types of brain lesions in Wernicke's encephalopathy. Neuropathol. Appl. Neurobiol. 11:179-190.
56. Troncoso, J.C., Johnston, M.V., Hess, K.M., Griffin, J.W., and Price, D.L. (1981). Model of Wernicke's Encephalopathy. Arch. Neurol. 38:350-354.
57. Victor, M., Adams, R.D., and Collins, G.H. (1989). The Wernicke-Korsakoff Syndrome and Related Neurologic Disorders Due to Alcoholism and Malnutrition, 2nd Ed., Philadelphia, F.A. Davies.
58. Vogel, S., and Hakim, A.M. (1988). Effect of nimodipine on the regional cerebral acidosis accompanying thiamine deficiency in the rat. J. Neurochem. 51:1102-1110.
59. Vortmeyer, A.O., and Colmant, H.J. (1988). Differentiation between brain lesions in experimental thiamine deficiency. Virchows Archiv. A. Pathol. Anat. 414:61-67.
60. Yokote, K., Miyagi, K., Kuzuhara, S., Yamanouchi, H., and Yamada, H. (1991). Wernicke encephalopathy: follow-up study by CT and MR. J. Comput. Assist. Tomogr. 15;835-838.
61. Zavala, F., Haumont, J., and Lenfant, M. (1984). Interaction of benzodiazepines with mouse macrophages. Eur. J. Pharmacol. 106;561-566.